التفاصيل البيبلوغرافية
العنوان:
Gut microbiome: a key player in cancer immunotherapy
المؤلفون:
Kentaro Inamura , Yasuyuki Shigematsu
المصدر:
Hepatobiliary surgery and nutrition . 7(6)
سنة النشر:
2019
مصطلحات موضوعية:
business.industry , animal diseases , medicine.medical_treatment , Cancer , chemical and pharmacologic phenomena , biochemical phenomena, metabolism, and nutrition , medicine.disease , Gut microbiome , Effector T-Lymphocyte , 03 medical and health sciences , Editorial , 0302 clinical medicine , Immune system , Cancer immunotherapy , 030220 oncology & carcinogenesis , medicine , Cancer research , bacteria , Cytotoxic T cell , 030212 general & internal medicine , business , Receptor , CD8
الوصف:
Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic approaches used to treat cancer. Immune checkpoint molecules located on tumor cells interact with receptors on cytotoxic CD8+ T cells (a type of effector T lymphocyte) and consequently lead to evasion of tumor cells from the immune system.
تدمد:
2304-3881
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b7f95f8c9fb679e77dc38db7097dfc https://pubmed.ncbi.nlm.nih.gov/29097494
حقوق:
OPEN
رقم الأكسشن:
edsair.doi.dedup.....e1b7f95f8c9fb679e77dc38db7097dfc
قاعدة البيانات:
OpenAIRE
